Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?

评估接受 HER2 抑制剂治疗的乳腺癌患者的心脏毒性：放射性核素心室造影和心脏生物标志物的组合能否预测对心脏的影响？